OPKO's Prostate Cancer Test A $2 Billion Market Opportunity
I have an insider's take on Wall Street
FOLLOW ON FORBES (163)
Opinions expressed by Forbes Contributors are their own.
The cash register is ringing at OPKO Health (OPK), which spells great news for investors. Last week, OPKO announced that its 4Kscore test for the detection of prostate cancer has been granted a Level I CPT code, which sets the stage for OPKO to finalize negotiations with insurance payers on reimbursement rates, meaning the test will get health insurance coverage.
Earlier this year, the National Comprehensive Cancer Network (NCCN), an alliance of the world’s leading cancer centers, recommended the 4Kscore test for the early detection of prostate cancer. Prior to the introduction of the 4Kscore test in 2014, a high prostate specific antigen (PSA) reading led to many false alarms, but to be safe men opted to have biopsies performed anyway. As a result, more than one million unnecessary biopsies occur every year, costing the U.S. healthcare system about $1.5 billion.
The 4Kscore diagnostic test is the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive cancer. In recommending the 4Kscore test, the NCCN panel stated that “the challenge is to minimize immediate treatment (over-treatment) of indolent cancers by accurately characterizing the biology of the detected cancer.” The “identification and selective treatment of aggressive cancers,” the NCCN pointed out, “should result in significant decreases in morbidity and mortality while limiting adverse effects on quality of life.”
The 4Kscore test incorporates measured levels of four prostate-specific kallikrein proteins – total PSA, free PSA, intact PSA and human Kallikrein-2 (hK2), plus the patient’s clinical information – into a proprietary algorithm to calculate an individual patient’s recent risk for aggressive prostate cancer. The four Kallikrein-2 panel of biomarkers
Great information and outcome---- bring it on--- orphan status with the FDA since there is little to nothing out here for those with Autism.
With all of his efforts and the efforts of the entire afrezza project on the line of complete mis- marketing---- I sure trust he will swing those puppies and demand more of his team--SNF-- or take his product back and prove SNF was sandbagging the agreement. Because none of this makes any sense to me. AFrezza is amazingly --- cutting edge --- .
Remember when SNF dismissed the President (?) of the division who actually I believe worked to secure afrezza? Said something about him spending too much time in USA and wanting to close down some of the less profitable locations in France? Wonder where he is now I know it was a biotech in Boston. Perhaps he too has tiene bolas de acero willing to take on the amazing afrezza.
Sentiment: Strong Buy
At high noon RCPI will be listed exactly where it should be. All things equal perhaps this is a healthier sector for the company to be placed. I have another stock seeef (14) in the same arena and waiting for results therein.
I believe in anatabloc b/c I used it.
I removed my $ at a significant loss none the less I learned a very valuable costly lesson- because everyday is a school day.
I remember attending the annual meeting and hearing Dr. and being impressed. But when the other Chap spoke my hairs on my neck stood up. After working for many years with many people I just felt this was a disingenuine display. Gut feeling. I also wanted to remove my $ then but felt an emotional tie since I was taking the product and understood how it was effecting me.
Wishing them good success and a return of anatibloc to market.
Good day to all and good profitable trading to all.
During the small pox epidemic --Did you know in the 1800's China actually came up with the idea to inhale the small pox (what we now know as) vaccine? Pretty amazing--- back to the future kind of medicine.
Only after this did we begin to vaccinate. Fast forward 2015 when we think we are so advanced and perhaps arrogent to believe wiser -- and we question the use of an inhaled treatment for a now epidemic health problem -- we are silly humans.
We are not human beings on a spirtual journey,
But spiritual beings on a human journey.
Pierre Teilhard de Chardin
Sentiment: Strong Buy
I have personally lost too many friends to this disease for the exact reason you mention MA67-- Doc's have a very hard time diagnosing OC. Most of the time patient's present with abdominal discomfort and the dr.'s misdiagnosing and waiting too long to treat.
Just amazing the recommendations for Mamograms is now being altered. Really pathetic.
Sentiment: Strong Buy
mix..... You think cramer & his team has the mojo....... think again Ms. Oprah is a very wise women and no manipulation just increasing the business --you know the old fashion way--- product ---sales#$%$ Refreshing
For reasons unknown the post was deleted by Yahoo. I can not explain why--- Catch up next week. Stay in good health.